Resilience Through Progress: Slow Growing Non-Hodgkin Lymphoma (NHL)
December 1, 2023
Topics Covered
We invite you to learn more about:
- How your NHL subtype determines treatment goals and strategies
- Navigating the uncertainty of a chronic disease
- New therapies on the horizon
- Methods to manage side effects
Program Materials
Speaker
J.C. Villasboas B., MD
Assistant Professor, Medicine and Oncology
Mayo Clinic College of Medicine and Science
Consultant, Division of Hematology
Director, Mayo Clinic Immune Monitoring
Core Laboratory
Mayo Clinic
Rochester, MN
Program Support
Support for this program provided by Genentech, Inc. & Biogen and Kite, a Gilead Company.